Osamu Tetsu
Publications by Year
Research Areas
Cancer-related Molecular Pathways, Salivary Gland Tumors Diagnosis and Treatment, Lung Cancer Treatments and Mutations, PI3K/AKT/mTOR signaling in cancer, Ubiquitin and proteasome pathways
Most-Cited Works
- → β-Catenin regulates expression of cyclin D1 in colon carcinoma cells(1999)3,586 cited
- → Germline Mutations in Genes Within the MAPK Pathway Cause Cardio-facio-cutaneous Syndrome(2006)568 cited
- → Proliferation of cancer cells despite CDK2 inhibition(2003)463 cited
- → A Critical Role for FBXW8 and MAPK in Cyclin D1 Degradation and Cancer Cell Proliferation(2006)200 cited
- → The Role of mel-18, a Mammalian Polycomb Group Gene, during IL-7–Dependent Proliferation of Lymphocyte Precursors(1997)109 cited
- → Cancer Targets in the Ras Pathway(2005)107 cited
- → Genetic Profiling Reveals Cross-Contamination and Misidentification of 6 Adenoid Cystic Carcinoma Cell Lines: ACC2, ACC3, ACCM, ACCNS, ACCS and CAC2(2009)103 cited
- → EGFR inhibition evokes innate drug resistance in lung cancer cells by preventing Akt activity and thus inactivating Ets-1 function(2015)102 cited
- → Inhibition of ERK1/2 down-regulates the Hippo/YAP signaling pathway in human NSCLC cells(2015)101 cited
- → Drug Resistance to EGFR Inhibitors in Lung Cancer(2016)99 cited